Concourse Financial Group Securities, Inc. Humacyte, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
15 transactions
Others Institutions Holding HUMA
# of Institutions
164Shares Held
50.8MCall Options Held
1.1MPut Options Held
808K-
Vanguard Group Inc Valley Forge, PA7.52MShares$9.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$5.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$3.72 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.64MShares$3.33 Million0.01% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $130M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...